<bill session="107" type="h" number="1387" updated="2013-07-14T18:57:32-04:00">
  <state datetime="2001-04-04">REFERRED</state>
  <status>
    <introduced datetime="2001-04-04"/>
  </status>
  <introduced datetime="2001-04-04"/>
  <titles>
    <title as="introduced" type="short">Drug Availability and Health Care Access Improvement Act of 2001</title>
    <title as="introduced" type="official">To amend the Social Security Act to improve access to prescription drugs for low-income Medicare beneficiaries, the Internal Revenue Code and other Acts to improve access to health care coverage for seniors, the self-employed, and children, and to amend the Federal Food, Drug, and Cosemetic Act to improve meaningful access to reasonably priced prescription drugs.</title>
  </titles>
  <sponsor id="400517"/>
  <cosponsors>
    <cosponsor id="400093" joined="2002-05-23"/>
    <cosponsor id="400121" joined="2001-04-04"/>
    <cosponsor id="400140" joined="2001-04-04"/>
    <cosponsor id="400149" joined="2001-04-04"/>
    <cosponsor id="400164" joined="2001-04-04"/>
    <cosponsor id="400506" joined="2001-04-04"/>
    <cosponsor id="400207" joined="2001-04-04"/>
    <cosponsor id="400209" joined="2001-04-04"/>
    <cosponsor id="400236" joined="2001-04-04"/>
    <cosponsor id="400357" joined="2001-04-04"/>
    <cosponsor id="400400" joined="2001-04-04"/>
    <cosponsor id="400611" joined="2001-04-04"/>
    <cosponsor id="400438" joined="2001-04-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2001-04-04">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2001-04-04">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2001-04-04">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2001-04-24">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2001-04-25">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Capitation (Medical care)"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Crime and law enforcement"/>
    <term name="Drug adulteration"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Finance and financial sector"/>
    <term name="Foreign trade and international finance"/>
    <term name="Fraud"/>
    <term name="Government operations and politics"/>
    <term name="Governmental investigations"/>
    <term name="Health maintenance organizations"/>
    <term name="Imports"/>
    <term name="Insurance premiums"/>
    <term name="Intellectual property"/>
    <term name="Intergovernmental fiscal relations"/>
    <term name="Labeling"/>
    <term name="Managed care"/>
    <term name="Medicaid"/>
    <term name="Medicaid managed care"/>
    <term name="Medical economics"/>
    <term name="Medicare"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Product counterfeiting"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
    <term name="Welfare eligibility"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary>4/4/2001--Introduced.
Drug Availability and Health Care Access Improvement Act of 2001 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require State Medicaid plans to cover prescribed drugs for qualified Medicare (SSA title XVIII) and other low-income Medicare beneficiaries.Provides full Federal funding for such Medicaid coverage.Amends SSA title XVIII part C (Medicare+Choice), as amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, with respect to access to Medicare+Choice plans through an increase in the minimum Medicare+Choice capitation rate.Amends the Federal Food, Drug, and Cosmetic Act with respect to the program for importation of certain prescription drugs by pharmacists and wholesalers to: (1) revise importer drug testing requirements; (2) prohibit drug manufacturers from discriminating against U.S. pharmacists, wholesalers, or consumers; and (3) changes from the Secretary of Health and Human Services to the Comptroller General responsibility for a specified study on drug imports.</summary>
</bill>
